Susan Halabi
Active 1992–2025
- 154
- Papers
- 28,114
- Citations
- 81
- h-index
- 147
- i10-index
Citations
Citation sources
Countries
Institutions
Fields
- Medicine80.2%
- Biochemistry, Genetics and Molecular Biology13.1%
- Immunology and Microbiology2.3%
- Computer Science0.8%
- Mathematics0.5%
- Nursing0.5%
- Other2.6%
Topics
- Prostate Cancer Treatment and Research14%
- Prostate Cancer Diagnosis and Treatment8.5%
- Radiopharmaceutical Chemistry and Applications4.1%
- Cancer Genomics and Diagnostics3.1%
- Renal cell carcinoma treatment3.1%
- Cancer Immunotherapy and Biomarkers3%
- Other64.2%
Coauthors
- Eric J. Small46
- Andrew J. Armstrong33
- Daniel J. George32
- Michael J. Morris28
- Richard L. Schilsky20
- Elizabeth Garrett‐Mayer19
- Karim Fizazi18
- Nicholas J. Vogelzang17
- Pam K. Mangat17
- Philip W. Kantoff17
- Himisha Beltran16
- Emmanuel S. Antonarakis14
- Johann S. de Bono14
- Joel Picus13
- Walter M. Stadler13
- Christopher J. Sweeney12
- Eugene R. Ahn11
- Howard I. Scher11
- Mary‐Ellen Taplin11
- Silke Gillessen11
- Tomasz M. Beer11
- William Kevin Kelly11
- Charles J. Ryan10
- Michael A. Carducci10
All papers
- Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3
Authors: Howard I. Scher, Michael J. Morris, Walter M. Stadler, Celestia S. Higano, Ethan Basch, Karim Fizazi, Emmanuel S. Antonarakis, Tomasz M. Beer, Michael A. Carducci, Kim N., Paul G. Corn, Johann S. de Bono, Robert Dreicer, Daniel J. George, Elisabeth I. Heath, Maha Hussain, Wm. Kevin Kelly, Glenn Liu, Christopher J. Logothetis, David M. Nanus, Mark N. Stein, Dana E. Rathkopf, Susan F. Slovin, Charles J. Ryan, Oliver Sartor, Eric J. Small, Matthew Raymond Smith, Cora N. Sternberg, Mary-Ellen Taplin, George Wilding, Peter S. Nelson, Lawrence H. Schwartz, Susan Halabi, Philip W. Kantoff, Andrew J. Armstrong - Journal of Clinical Oncology 2016 cited by 1,603
- The Lancet Commission on prostate cancer: planning for the surge in cases
Authors: Nicholas D. James, Ian F. Tannock, James N’Dow, Felix Y. Feng, Silke Gillessen, Syed Adnan Ali, Blanca Trujillo, Bissan Al‐Lazikani, Gerhardt Attard, Freddie Bray, Éva Compérat, Rosalind A. Eeles, Omolara Fatiregun, Emily Grist, Susan Halabi, Áine Haran, Daniel Herchenhorn, Michael S. Hofman, Mohamed Jalloh, Stacy Loeb, Archie Macnair, Brandon A. Mahal, Larissa Mendes, Masood Moghul, Caroline M. Moore, Alicia K. Morgans, Michael J. Morris, Declan G. Murphy, Vedang Murthy, Paul L. Nguyen, Anwar R. Padhani, Charles Parker, Hannah Rush, Mark Sculpher, Howard R. Soule, Matthew R. Sydes, Derya Tilki, Nina Tunariu, Paul Villanti, Liping Xie - The Lancet 2024 cited by 643
- Management of patients with advanced prostate cancer—metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022
Authors: Silke Gillessen, Alberto Bossi, Ian D. Davis, Johann S. de Bono, Karim Fizazi, Nicholas D. James, Nicolas Mottet, Neal D. Shore, Eric J. Small, Matthew R. Smith, Christopher J. Sweeney, Bertrand Tombal, Emmanuel S. Antonarakis, Ana M. Aparicio, Andrew J. Armstrong, Gerhardt Attard, Tomasz M. Beer, Himisha Beltran, Anders Bjartell, Pierre Blanchard, Alberto Briganti, Robert G. Bristow, Muhammad Bulbul, Orazio Caffo, Daniel Castellano, Elena Castro, Heather H. Cheng, Kim N., Simon Chowdhury, Caroline S. Clarke, Noel W. Clarke, Gedske Daugaard, Maria De Santis, Ignacio Durán, Ross Eeles, Eleni Efstathiou, Jason A. Efstathiou, Onyeanunam Ngozi Ekeke, Christopher P. Evans, Stefano Fanti, Felix Y. Feng, Valérie Fonteyne, Nicola Fossati, Mark Frydenberg, Dan George, Martin Gleave, Gwénaëlle Gravis, Susan Halabi, Daniel Heinrich, Ken Herrmann, Celestia Higano, Michael S. Hofman, Lisa G. Horvath, Maha Hussain, Barbara Alicja Jereczek‐Fossa, Robert J. Jones, Ravindran Kanesvaran, Pirkko‐Liisa Kellokumpu‐Lehtinen, Raja B. Khauli, Laurence Klotz, Gero Kramer, Raja Leibowitz, Christopher Logothetis, Brandon A. Mahal, Fernando Cotait Maluf, Joaquı́n Mateo, David Matheson, Niven Mehra, Axel S. Merseburger, Amee Morgans, Michael J. Morris, Hind Mrabti, Deborah Mukherji, Declan G. Murphy, Vedang Murthy, Paul L. Nguyen, William Oh, Piet Ost, Joe M. O’Sullivan, Anwar R. Padhani, Carmel Pezaro, Darren M.C. Poon, Colin C. Pritchard, Danny Rabah, Dana E. Rathkopf, Robert E. Reiter, Mark A. Rubin, Charles J. Ryan, Fred Saad, Juan Pablo Sade, Oliver Sartor, Howard I. Scher, Nima Sharifi, Iwona Skoneczna, Howard R. Soule, Daniel E. Spratt, Sandy Srinivas, Cora N. Sternberg, Thomas Steuber, Hiroyoshi Suzuki and 18 more - European Journal of Cancer 2023 cited by 157
- Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group
Authors: Howard I. Scher, Susan Halabi, Ian F. Tannock, Michael J. Morris, Cora N. Sternberg, Michael A. Carducci, Mario A. Eisenberger, Celestia S. Higano, Glenn J. Bubley, Robert Dreicer, Daniel Petrylak, Philip W. Kantoff, Ethan Basch, William Kevin Kelly, William D. Figg, Eric J. Small, Tomasz M. Beer, George Wilding, Alison Martin, Maha Hussain - Journal of Clinical Oncology 2008 cited by 2,241
- Prospective Multicenter Validation of Androgen Receptor Splice Variant 7 and Hormone Therapy Resistance in High-Risk Castration-Resistant Prostate Cancer: The PROPHECY Study
Authors: Andrew J. Armstrong, Susan Halabi, Jun Luo, David M. Nanus, Paraskevi Giannakakou, Russell Z. Szmulewitz, Daniel C. Danila, Patrick Healy, Monika Anand, Colin Rothwell, Julia Rasmussen, Blair Thornburg, William R. Berry, Rhonda Wilder, Changxue Lu, Yan Chen, John L. Silberstein, Gabor Kemeny, Giuseppe Galletti, Jason A. Somarelli, Santosh Gupta, Simon G. Gregory, Howard I. Scher, Ryan Dittamore, Scott T. Tagawa, Emmanuel S. Antonarakis, Daniel J. George - Journal of Clinical Oncology 2019 cited by 364
- Meta-Analysis Evaluating the Impact of Site of Metastasis on Overall Survival in Men With Castration-Resistant Prostate Cancer
Authors: Susan Halabi, William Kevin Kelly, Hua Ma, Hao Zhou, Nicole Solomon, Karim Fizazi, Catherine M. Tangen, Mark Rosenthal, Daniel P. Petrylak, Maha Hussain, Nicholas J. Vogelzang, Ian M. Thompson, Kim N., Johann S. de Bono, Andrew J. Armstrong, Mario A. Eisenberger, Abderrahim Fandi, Shaoyi Li, John C. Araujo, Christopher J. Logothetis, David I. Quinn, Michael J. Morris, Celestia S. Higano, Ian F. Tannock, Eric J. Small - Journal of Clinical Oncology 2016 cited by 463
- Metastasis-Free Survival Is a Strong Surrogate of Overall Survival in Localized Prostate Cancer
Authors: Wanling Xie, Meredith M. Regan, Marc Buyse, Susan Halabi, Philip W. Kantoff, Oliver Sartor, Howard R. Soule, Noel W. Clarke, Laurence Collette, James J. Dignam, Karim Fizazi, Wendy R. Paruleker, Howard M. Sandler, Matthew R. Sydes, Bertrand Tombal, Scott Williams, Christopher J. Sweeney, on behalf of the ICECaP Working Group - Journal of Clinical Oncology 2017 cited by 434
- Association of Black Race With Prostate Cancer–Specific and Other-Cause Mortality
Authors: Robert T. Dess, Holly Hartman, Brandon A. Mahal, Payal Soni, Will Jackson, Matthew R. Cooperberg, Christopher L. Amling, William J. Aronson, Christopher J. Kane, Martha K. Terris, Zachary S. Zumsteg, Santino Butler, Joseph R. Osborne, Todd M. Morgan, Rohit Mehra, Simpa S. Salami, Amar U. Kishan, Chenyang Wang, Edward M. Schaeffer, Mack Roach, Thomas M. Pisansky, William U. Shipley, Stephen J. Freedland, Howard M. Sandler, Susan Halabi, Felix Y. Feng, James J. Dignam, Paul L. Nguyen, Matthew J. Schipper, Daniel E. Spratt - JAMA Oncology 2019 cited by 409
- Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022
Authors: Silke Gillessen, Alberto Bossi, Ian D. Davis, Johann S. de Bono, Karim Fizazi, Nicholas D. James, Nicolas Mottet, Neal D. Shore, Eric J. Small, Matthew R. Smith, Christopher J. Sweeney, Bertrand Tombal, Emmanuel S. Antonarakis, Ana M. Aparicio, Andrew J. Armstrong, Gerhardt Attard, Tomasz M. Beer, Himisha Beltran, Anders Bjartell, Pierre Blanchard, Alberto Briganti, Robert G. Bristow, Muhammad Bulbul, Orazio Caffo, Daniel Castellano, Elena Castro, Heather H. Cheng, Kim N., Simon Chowdhury, Caroline S. Clarke, Noel W. Clarke, Gedske Daugaard, Maria De Santis, Ignacio Durán, Rosalind A. Eeles, Eleni Efstathiou, Jason A. Efstathiou, Onyeanunam Ngozi Ekeke, Christopher P. Evans, Stefano Fanti, Felix Y. Feng, Valérie Fonteyne, Nicola Fossati, Mark Frydenberg, Daniel J. George, Martin Gleave, Gwénaëlle Gravis, Susan Halabi, Daniel Heinrich, Ken Herrmann, Celestia S. Higano, Michael S. Hofman, Lisa G. Horvath, Maha Hussain, Barbara Alicja Jereczek‐Fossa, Robert J. Jones, Ravindran Kanesvaran, Pirkko‐Liisa Kellokumpu‐Lehtinen, Raja B. Khauli, Laurence Klotz, Gero Kramer, Raya Leibowitz‐Amit, Christopher J. Logothetis, Brandon A. Mahal, Fernando Cotait Maluf, Joaquı́n Mateo, David Matheson, Niven Mehra, Axel S. Merseburger, Alicia K. Morgans, Michael J. Morris, Hind Mrabti, Deborah Mukherji, Declan G. Murphy, Vedang Murthy, Paul L. Nguyen, William Oh, Piet Ost, Joe M. O’Sullivan, Anwar R. Padhani, Carmel Pezaro, Darren M.C. Poon, Colin C. Pritchard, Danny Rabah, Dana E. Rathkopf, Robert E. Reiter, Mark A. Rubin, Charles J. Ryan, Fred Saad, Juan Pablo Sade, Oliver A. Sartor, Howard I. Scher, Nima Sharifi, Iwona Skoneczna, Howard R. Soule, Daniel E. Spratt, Sandy Srinivas, Cora N. Sternberg, Thomas Steuber, Hiroyoshi Suzuki and 18 more - European Urology 2022 cited by 118
- Cabozantinib Versus Sunitinib As Initial Targeted Therapy for Patients With Metastatic Renal Cell Carcinoma of Poor or Intermediate Risk: The Alliance A031203 CABOSUN Trial
Authors: Toni K. Choueiri, Susan Halabi, Ben L. Sanford, Olwen Hahn, M. Dror Michaelson, Meghara Walsh, Darren R. Feldman, Thomas Olencki, Joel Picus, Eric J. Small, Shaker R. Dakhil, Daniel J. George, Michael J. Morris - Journal of Clinical Oncology 2017 cited by 715
- Everolimus versus sunitinib for patients with metastatic non-clear cell renal cell carcinoma (ASPEN): a multicentre, open-label, randomised phase 2 trial
Authors: Andrew J. Armstrong, Susan Halabi, Tim Eisen, Samuel Broderick, Walter M. Stadler, Robert J. Jones, Jorge A. García, Ulka N. Vaishampayan, Joel Picus, Robert E. Hawkins, John D. Hainsworth, Christian Kollmannsberger, Theodore F. Logan, Igor Puzanov, Lisa Pickering, Christopher W. Ryan, Andrew Protheroe, Christine M. Lusk, Sadie Oberg, Daniel J. George - The Lancet Oncology 2016 cited by 424
- Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma
Authors: Andrea B. Apolo, Karla V. Ballman, Guru Sonpavde, Stephanie Berg, William Y. Kim, Rahul Atul Parikh, Min Yuen Teo, Randy F. Sweis, Daniel M. Geynisman, Petros Grivas, Gurkamal Chatta, Zachery R. Reichert, Joseph W. Kim, Mehmet Asım Bilen, Bradley A. McGregor, Parminder Singh, Abhishek Tripathi, Suzanne Cole, Nicholas I. Simon, Scot A. Niglio, Lisa Ley, Lisa M. Cordes, Sandy Srinivas, Jiaoti Huang, Meagan Odegaard, Colleen Watt, Daniel P. Petrylak, Jeannie Hoffman-Censits, Yujia Wen, Olwen Hahn, Cecilia Mitchell, Alan W.C. Tan, Howard Streicher, Elad Sharon, Helen Moon, Michael Woods, Susan Halabi, Gabriela Perez Burbano, Michael J. Morris, Jonathan E. Rosenberg - New England Journal of Medicine 2024 cited by 145
- Pertuzumab Plus Trastuzumab in Patients With Colorectal Cancer WithERBB2Amplification orERBB2/3Mutations: Results From the TAPUR Study
Authors: R. Gupta, Funda Meric‐Bernstam, Michael Rothe, Elizabeth Garrett‐Mayer, Pam K. Mangat, Stacy D. D’Andre, Eugene R. Ahn, Raegan O'Lone, Susan Halabi, Gina N. Grantham, Richard L. Schilsky - JCO Precision Oncology 2022 cited by 61
- Cabozantinib versus sunitinib as initial therapy for metastatic renal cell carcinoma of intermediate or poor risk (Alliance A031203 CABOSUN randomised trial): Progression-free survival by independent review and overall survival update
Authors: Toni K. Choueiri, Colin Hessel, Susan Halabi, Ben L. Sanford, M. Dror Michaelson, Olwen Hahn, Meghara Walsh, Thomas Olencki, Joel Picus, Eric J. Small, Shaker R. Dakhil, Darren R. Feldman, Milan Mangeshkar, Christian Scheffold, Daniel J. George, Michael J. Morris - European Journal of Cancer 2018 cited by 400
- Pembrolizumab in Patients With Metastatic Breast Cancer With High Tumor Mutational Burden: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study
Authors: Ajjai Alva, Pam K. Mangat, Elizabeth Garrett‐Mayer, Susan Halabi, Damien Mikael Hansra, Carmen Calfa, Maged Khalil, Eugene R. Ahn, Timothy Lewis Cannon, Pamela Crilley, Julie Gottlieb Fisher, Derrick S. Haslem, Sagun Shrestha, Kaitlyn R. Antonelli, Nicole Butler, Sasha L. Warren, Andrew L. Rygiel, Shamika Ranasinghe, Suanna S. Bruinooge, Richard L. Schilsky - Journal of Clinical Oncology 2021 cited by 182
- Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Prostate Cancer: The Primary Results of the PRONOUNCE Randomized Trial
Authors: Renato D. Lópes, Celestia S. Higano, Susan F. Slovin, Adam J. Nelson, Robert Bigelow, Per Settergren Sørensen, Chiara Melloni, Shaun G. Goodman, Christopher P. Evans, Jan Nilsson, Deepak L. Bhatt, Noel W. Clarke, Tine Kold Olesen, Belinda T. Doyle-Olsen, Henriette Kristensen, Lauren Arney, Matthew T. Roe, John H. Alexander, Mirjam Mol-Arts, Samreen Mansor-Lefebvre, Konstantin Zubovskiy, Allan Blemings, Klaus A. Dugi, Gerald S. Bloomfield, Chris Kontos, Adam D DeVore, J. Dedrick Jordan, Brad J. Kolls, J. B. Matthews, Rajendra H. Mehta, Thomas J. Povsic, Michael Morse, Kenneth W. Mahaffey, Susan Halabi, Darryl P. Leong, Laurence Klotz, Neil Fleshner, G. Kenneth Jansz, Jonathan Giddens, R. Blair Egerdie, Joseph L. Chin, Joseph Zadra, Richard Casey, Jean Simard, Tamim Niazi, André‐Guy Martin, Marek Babjuk, Jaroslav Hájek, Jiří Klečka, Jiří Kubeš, Jan Schraml, Jitka Jakesova, J Vaňásek, Bohuslav Melichar, Heikki Seikkula, M. Abdiche, Marc Colombel, P. Debourdeau, G. Robert, Arnauld Villers, Guillaume Ploussard, Benjamin Pradère, F. Bruyère, Jean‐Luc Descotes, Idir Ouzaïd, Alexander Winter, Herbert Hanitzsch, H. Sperling, Ralf Eckert, Peter Hammerer, E. Stagge, F. Seseke, Silvio Szymula, Aristotelis Bamias, A. Thanos, Konstantinos Hatzimouratidis, Charalambos Mamoulakis, Haralabos P. Kalofonos, Elżbieta Oszukowska, Katarzyna Madziarska, Jacek Fijuth, Mateusz Obarzanowski, B. Yа. Alekseev, Vagif Atduev, Dmitri Pushkar, Evgeniy Veliev, A. V. Zyryаnov, С Б Петров, Evgeny Kopyltsov, Vadim Kozlov, Ladislav Macko, J. Dúbravický, Richard Polak, Obaidullah Mir, Marek Vargovcak, I. Minčík, J. Kliment, Frederico Gonçalves, J Mikuláš, Roman Sokol and 55 more - Circulation 2021 cited by 143
- Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017
Authors: Silke Gillessen, Gerhardt Attard, Tomasz M. Beer, Himisha Beltran, Alberto Bossi, Robert G. Bristow, Brett S. Carver, Daniel Castellano, Byung Ha Chung, Noel W. Clarke, Gedske Daugaard, Ian D. Davis, Johann S. de Bono, Rodolfo Borges dos Reis, Charles G. Drake, Rosalind A. Eeles, Eleni Efstathiou, Christopher P. Evans, Stefano Fanti, Felix Y. Feng, Karim Fizazi, Mark Frydenberg, Martin Gleave, Susan Halabi, Axel Heidenreich, Celestia S. Higano, Nicolas James, Philip W. Kantoff, Pirkko‐Liisa Kellokumpu‐Lehtinen, Raja B. Khauli, Gero Kramer, Chris Logothetis, Fernando Cotait Maluf, Alicia K. Morgans, Michael J. Morris, Nicolas Mottet, Vedang Murthy, William Oh, Piet Ost, Anwar R. Padhani, Chris Parker, Colin C. Pritchard, Mack Roach, Mark A. Rubin, Charles J. Ryan, Fred Saad, Oliver Sartor, Howard I. Scher, Avishay Sella, Neal D. Shore, Matthew R. Smith, Howard R. Soule, Cora N. Sternberg, Hiroyoshi Suzuki, Christopher J. Sweeney, Matthew R. Sydes, Ian F. Tannock, Bertrand Tombal, R. Valdagni, Thomas Wiegel, Aurelius Omlin - European Urology 2017 cited by 643
- Abatacept, Cenicriviroc, or Infliximab for Treatment of Adults Hospitalized With COVID-19 Pneumonia
Authors: Jane A. O’Halloran, Emily R. Ko, Kevin J. Anstrom, Eyal Kedar, Matthew W. McCarthy, Reynold A. Panettieri, Martin Maillo, Patricia Segura Nunez, Anne M. Lachiewicz, Cynthia Gonzalez, P. Brian Smith, Sabina Mendívil-Tuchía de Tai, Akram Khan, Alfredo J Mena Lora, Matthias Salathé, Gerardo Capo, Daniel González, Thomas F. Patterson, Christopher Palma, Horacio Ariza, Maria Patelli Juliani Souza Lima, John Blamoun, Esteban C. Nannini, Eduardo Sprinz, Analía Mykietiuk, Radica Z. Alicic, Adriana M. Rauseo, Cameron R. Wolfe, Britta Witting, Jennifer Wang, Luis Parra-Rodriguez, Tatyana Der, Kate Willsey, Jun Wen, A Silverstein, Sean M. O’Brien, Hussein R. Al‐Khalidi, Michael A. Maldonado, Richard Melsheimer, William Ferguson, Steven E. McNulty, Pearl Zakroysky, Susan Halabi, Daniel K. Benjamin, Sandra Butler, Jane C. Atkinson, Stacey J. Adam, Soju Chang, Lisa M. LaVange, Michael A. Proschan, Samuel A. Bozzette, William G. Powderly, ACTIV-1 IM Study Group Members, Mihir Patel, Arun J. Sanyal, Jason Green, Huimin Wu, Benjamin P. Linas, Philip Grant, Vivek Iyer, Otto O. Yang, Bindu Balani, Sam Parnia, Ryan K Dare, Caryn G. Morse, Estelle S. Harris, Glenn Wortmann, Nicholas S. Hill, Shama Patel, Julia Garcia‐Diaz, Suman Thapamager, Megan Devine, Christine M. Bojanowski, Barry Meisenberg, Gailen D. Marshall, Dima Dandachi, Arick P. Sabin, Anthony Breemo, Suman Sinha, Christopher H. Goss, Rebecca Reece, Arlette Aouad, Seth Glassman, Peter E. Morris, Bela Patel, Fatimah Bello, Juliana Cardozo Fernandes, Oscar Carbajal, L Ravera, Mozar Castro, Miguel Villegas-Chiroque, Fernando Riera, A. Casado Camacho, Claudio Stadnik, Jorge Gave, Rodrigo Biondi, Ronal Gamarra Velarde, José Cerbino Neto, J. Ditondo, Marcelo Losso and 258 more - JAMA 2023 cited by 67
- Updated Prognostic Model for Predicting Overall Survival in First-Line Chemotherapy for Patients With Metastatic Castration-Resistant Prostate Cancer
Authors: Susan Halabi, Chen‐Yen Lin, William K. Kelly, Karim Fizazi, Judd W. Moul, Ellen B. Kaplan, Michael J. Morris, Eric J. Small - Journal of Clinical Oncology 2014 cited by 475
- Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019
Authors: Silke Gillessen, Gerhardt Attard, Tomasz M. Beer, Himisha Beltran, Anders Bjartell, Alberto Bossi, Alberto Briganti, Robert G. Bristow, Kim N., Noel W. Clarke, Ian D. Davis, Johann S. de Bono, Charles G. Drake, Ignacio Durán, Rosalind A. Eeles, Eleni Efstathiou, Christopher P. Evans, Stefano Fanti, Felix Y. Feng, Karim Fizazi, Mark Frydenberg, Martin Gleave, Susan Halabi, Axel Heidenreich, Daniel Heinrich, Celestia S. Higano, Michael S. Hofman, Maha Hussain, Nicholas D. James, Ravindran Kanesvaran, Philip W. Kantoff, Raja B. Khauli, Raya Leibowitz‐Amit, Chris Logothetis, Fernando Cotait Maluf, Robin Millman, Alicia K. Morgans, Michael J. Morris, Nicolas Mottet, Hind Mrabti, Declan G. Murphy, Vedang Murthy, William Oh, Piet Ost, Joe M. O’Sullivan, Anwar R. Padhani, Chris Parker, Darren M.C. Poon, Colin C. Pritchard, Robert E. Reiter, Mack Roach, Mark A. Rubin, Charles J. Ryan, Fred Saad, Juan Pablo Sade, Oliver Sartor, Howard I. Scher, Neal D. Shore, Eric J. Small, Matthew R. Smith, Howard R. Soule, Cora N. Sternberg, Thomas Steuber, Hiroyoshi Suzuki, Christopher J. Sweeney, Matthew R. Sydes, Mary-Ellen Taplin, Bertrand Tombal, Levent Türkeri, Inge M. van Oort, A. Zapatero, Aurelius Omlin - European Urology 2020 cited by 395
- Rationale and Design of the Targeted Agent and Profiling Utilization Registry Study
Authors: Pam K. Mangat, Susan Halabi, Suanna S. Bruinooge, Elizabeth Garrett‐Mayer, Ajjai Alva, Katherine A. Janeway, Philip J. Stella, Emile E. Voest, Kathleen J. Yost, Jane Perlmutter, Navin Pinto, Edward S. Kim, Richard L. Schilsky - JCO Precision Oncology 2018 cited by 180
- Pembrolizumab in Patients With Tumors With High Tumor Mutational Burden: Results From the Targeted Agent and Profiling Utilization Registry Study
Authors: Herbert L. Duvivier, Michael Rothe, Pam K. Mangat, Elizabeth Garrett‐Mayer, Eugene R. Ahn, Tareq Al Baghdadi, Ajjai Alva, Stephanie A. Dublis, Timothy Lewis Cannon, Carmen Calfa, Rui Li, Deepti Behl, Vi K. Chiu, Philip J. Gold, Alissa Marr, Kathryn F. Mileham, Steven Powell, Jordi Rodón, Ramya Thota, Gina N. Grantham, Abigail Gregory, Dominique C. Hinshaw, Susan Halabi, Richard L. Schilsky - Journal of Clinical Oncology 2023 cited by 41
- Prostate Cancer Racial Disparities: A Systematic Review by the Prostate Cancer Foundation Panel.
Authors: Brandon A. Mahal, Travis Gerke, Shivanshu Awasthi, Howard R. Soule, Jonathan W. Simons, Andrea K. Miyahira, Susan Halabi, Daniel J. George, Elizabeth A. Platz, Lorelei A. Mucci, Kosj Yamoah - European Urology Oncology 2021 cited by 96
- Randomized Phase III Study of Enzalutamide Compared With Enzalutamide Plus Abiraterone for Metastatic Castration-Resistant Prostate Cancer (Alliance A031201 Trial)
Authors: Michael J. Morris, Glenn Heller, David W. Hillman, Olivia Bobek, Charles J. Ryan, Emmanuel S. Antonarakis, Alan H. Bryce, Olwen Hahn, Himisha Beltran, Andrew J. Armstrong, Lawrence B. Schwartz, Lionel D. Lewis, Jan H. Beumer, Brooke Langevin, Eric C. McGary, Paul Mehan, Amir Goldkorn, Bruce J. Roth, Han Xiao, Colleen Watt, Mary‐Ellen Taplin, Susan Halabi, Eric J. Small - Journal of Clinical Oncology 2023 cited by 52
